RedHill Biopharma to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call on February 22, 2018 TEL-AVIV, Israel and RALEIGH, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical...

RedHill Biopharma Reports 2014 Fourth Quarter and Year-End Financial Results Key Highlights Include: Strong cash position of over $34 million, following completion of a $14.4 million U.S. public offering in February 2015 With three ongoing Phase III clinical...

Actua to Announce Fourth Quarter and Year End 2014 Results Thursday, February 19th Before Market Opens RADNOR, Pa., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Actua Corporation (Nasdaq:ACTA), formerly ICG Group, Inc., will release the financial results for its fourth quarter and full-year ended December 31, 2014...